Inovio Clinical Trials: Infectious Disease

Inovio Biomedical is involved with one or more partners in the following ongoing clinical trials for the treatment of infectious diseases. Patients are being recruited for these trials as detailed below.

Indication: Chronic hepatitis C virus infection

Treatment: ChronVac-C® + electroporation

Trial Stage: Phase I/IIa

• Chronic hepatitis C virus, genotype 1 infected, low viral load, treatment naive
• Study design: Open label, dose ranging; safety, tolerability, and efficacy study
• Centers in Sweden (contact: ola.weiland@ki.se)
• For more information see http://tripep.se/english/start/
• Clinical trial description: http://www.clinicaltrials.gov/ct2/show/NCT00563173?term=tripep&rank=1